We’re pleased to publish our Year in Review for 2025-26, highlighting how innovation is improving access to care, speeding up diagnosis, supporting business growth, and helping NHS and social care teams adopt new technologies.
The Spread & Scale Academy is now accepting applications for its next cohort. This is your chance to take something that already works and give it the reach it deserves. This is the sixth year running the Academy as part of the All-Wales Intensive Learning Academy for Innovation in Health and Social Care
The life sciences industry in Wales is set to benefit from more direct engagement with the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
The Welsh NHS Confederation has launched a new and comprehensive health and care glossary to support understanding of the complex terminology used across the health and social care sector in Wales.
Working closely with our Senior Leadership Team and Board, Catrin joins our Senior Management Team and will lead the planning and delivery of programmes that help identify, evaluate and implement health and social care innovation across Wales.
The Henry Royce Institute (Royce) has opened applications for technology leads and founders to bring forward opportunities for the next Royce Catalyst cohorts, where interdisciplinary teams explore the commercial feasibility of early-stage advanced materials technologies.
Three innovative projects aimed at improving stroke care for patients across Wales have been awarded funding following the country’s first ever Stroke Technology Symposium.
A new report released to coincide with the 2026 Wales Cancer Research Conference highlights the impact of Wales’ first unified cancer research strategy three years after its launch.
The National Cardiovascular Research Network (NCRN) has secured landmark funding that will transform efforts to prevent, diagnose and treat heart disease across Wales.
Held every two years, the Moondance Cancer Awards celebrate and spotlight individuals, teams and collaborations across NHS Wales and its partners who deliver, lead and innovate cancer services.
The NHS Wales Joint Commissioning Committee (NWJCC), working with Life Sciences Hub Wales as part of the Welsh Government Tackling Cancer Initiative, are piloting a national pathway to identify cancer treatments, technologies and approaches which should be prioritised for adoption across Wales.
Health Technology Wales has published new guidance recommending the routine adoption of capsule sponge devices to detect Barrett's oesophagus and early-stage oesophageal cancer in people with chronic reflux.
Construction on the National Institute for Sport and Health (NISH), a pioneering new centre dedicated to advancing health, sport, and technology innovation is due to begin.
A major £2.52 million investment will accelerate the use of cutting-edge liquid biopsy technology that analyses cancer DNA from a blood sample, supporting faster and more personalised treatment decisions.
The Dragon’s Heart Institute is delighted to announce that the next Spread and Scale Academy will take place between 10 and 12 March 2026 at Sophia Gardens Cricket Ground in Cardiff. Applications are now open and will close on 8 January 2026.
We’ve joined forces with Macmillan Cancer Support to launch a partnership, aiming to accelerate the pace of innovation in cancer care and improve outcomes for people affected by cancer across Wales.
Amgen has joined forces with the Welsh Government, Swansea University, and Life Sciences Hub Wales to transform the future of healthcare, pledging support to a charter focused on advancing value-based healthcare and innovation across Wales.
We’re delighted to sponsor this year’s NHS Wales Awards, a prestigious annual event that celebrates exceptional achievements across health and social care in Wales.
Life Sciences Hub Wales is proud to be a main sponsor of this year’s Welsh NHS Confederation Annual Conference and Exhibition. We’re also hosting a breakout session exploring how Wales is harnessing the power of innovation to transform cancer care.
Life Sciences Hub Wales and the Academy of Medical Sciences have launched their Cancer Care Accelerator Fund. Up to £10,000 in seed funding alongside bespoke support is now available for UK-based organisations working on collaborative cancer innovation projects.
Our Annual Report for 2024-25 highlights how cross-sector collaboration is tackling real-world challenges and making a lasting difference to the health, wealth, and wellbeing of Wales and its people.
Following the rollout of the Virtual Reality (VR) training programme for social care staff in Bridgend in March 2025, the project is continuing to make significant impact, enhancing staff competency.
